Assessing social risks prior to commencement of a clinical trial: due diligence or ethical inflation? [electronic resource]
Producer: 20091214Description: 48-54 p. digitalISSN:- 1536-0075
- Adult
- Buprenorphine -- therapeutic use
- Buprenorphine, Naloxone Drug Combination
- China
- Confidentiality -- ethics
- Conflict of Interest
- Counseling
- Ethics Committees, Research -- ethics
- Ethics, Research
- Female
- Financing, Government
- HIV Infections -- etiology
- Health Services Accessibility -- ethics
- Human Rights
- Humans
- Informed Consent -- ethics
- International Cooperation
- Male
- Middle Aged
- Naloxone -- therapeutic use
- Narcotic Antagonists -- therapeutic use
- Opioid-Related Disorders -- complications
- Patient Selection -- ethics
- Randomized Controlled Trials as Topic -- economics
- Research Design
- Research Subjects
- Risk Assessment
- Risk Reduction Behavior
- Social Environment
- Thailand
- United States
- Vulnerable Populations
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.